reata pharmaceuticals inc stock price

Get the latest Reata Pharmaceuticals Inc. NASDAQRETA - Get Ratings share price was up 47 during mid-day trading on Tuesday after Citigroup raised their price target on the stock.


Reata Pharmaceuticals Inc Our Science Our Technologies Nrf2 Activators

View the latest Reata Pharmaceuticals Inc.

. 10 hours agoRTTNews - The US. RETA stock price news buy or sell recommendation and investing advice from Wall Street professionals. 6 Wall Street analysts have issued 1 year price objectives for Reata Pharmaceuticals stock.

Reata Pharmaceuticals Inc. Investment amount Start date. RETA Reata the Company our us or we a clinical-stage biopharmaceutical company.

Reatas development programs have created a robust pipeline of drug candidates for the treatment of serious life-threatening diseases. 16 hours agoReata Pharmaceuticals Inc. Cl A RETA stock price news historical charts analyst ratings and financial information from WSJ.

Reata Pharmaceuticals Inc - Ordinary Shares - Class A 2354 088 360 Watch. 6 days ago Commit To Purchase Reata Pharmaceuticals At 2250 Earn 267 Using Options. Their RETA share price forecasts range from 2700 to 11200.

A high-level overview of Reata Pharmaceuticals Inc. Get the latest Reata Pharmaceuticals Inc RETA real-time quote historical performance charts and other financial information to help you make more informed trading and investment. 7600 of the stock is owned by institutional.

View the latest Reata Pharmaceuticals Inc. Food and Drug Administration has informed Reata Pharmaceuticals Inc. Cl A RETA stock price news historical charts analyst ratings and financial information from WSJ.

RETA Reata the Company our us or we a clinical-stage biopharmaceutical company announced that the US. PLANO Texas October 13 2022--Reata Pharmaceuticals Inc. Bought a new position in Reata Pharmaceuticals in the second quarter worth about 224000.

Not an offer or recommendation by Stocktwits. Reata Pharmaceuticals NASDAQRETA Get Rating had its target price upped by stock analysts at Citigroup from 4000 to 4800 in a note issued to investors on Tuesday. View Reata Pharmaceuticals Inc RETA investment stock information.

Class A Common Stock RETA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. RETA Reata the Company our us or we a clinical-stage biopharmaceutical company announced that the US. 1 day agoFinally Principal Financial Group Inc.

Stock analysis for Reata Pharmaceuticals Inc RETANASDAQ GM including stock price stock chart company news key statistics fundamentals and company profile. RETA that it does not plan to hold an advisory commit. Reata Pharmaceuticals Inc Class A - Stock Quote RETA Morningstar2c Inc.

Get Reata Pharmaceuticals Inc RETANASDAQ real-time stock quotes news price and financial information from CNBC. Find out more here. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

Get the latest Reata Pharmaceuticals Inc RETA detailed stock quotes stock data Real-Time ECN. Reata Pharmaceuticals Inc.


Reta Def14a 20210610 Htm


Reta Reata Pharmaceuticals Stock Price


Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis


Reata Pharmaceuticals Inc Reta Stock 52 Week High Low


Kop Reata Pharmaceuticals Incaktier Se Reta Reata Pharmaceuticals Incs Aktiekurs Pa Etoro


Reata Pharmaceuticals Share Price Reta Stock Quote Charts Trade History Share Chat Financials Reata Pharmaceuticals Inc Class A Common Stock


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S


Reata Reta Stock Down Despite Q2 Earnings Sales Beat Nasdaq


Reata Pharmaceuticals Inc Reta Reports Q2 Loss Lags Revenue Estimates


Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis


Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis


Reata Reta Friedreich S Ataxia Nda Gets Priority Review Nasdaq


Plano Based Drug Developer Reata Raises 505 Million Expects To Double To 400 Employees By End Of 2020


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S


Analysts Estimate Reata Pharmaceuticals Inc Reta To Report A Decline In Earnings What To Look Out For Nasdaq


Reata Pharmaceuticals Inc Share Price Ord Class A


Reata Reta Q2 Earnings Miss Revenues Down Y Y Stock Down


Reata Pharmaceuticals Inc Compassionate Use


Why Reata Pharmaceuticals Stock Is Plunging Today The Motley Fool

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel